Goldman Sachs Group Inc Nex Immune, Inc. Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 14, 2024	BUY	$0.21 - $18.5 $188,340 - $16.6 Million	896,861 Added 3083.69%	925,945 $222,000
Q4 2022 Feb 13, 2023	BUY	$0.21 - $18.5 $194,448 - $17.1 Million	925,945 New	925,945 $222,000
Q2 2022 May 14, 2024	BUY	$1.61 - $4.68 $46,825 - $136,113	29,084 New	29,084 $47,000
Q2 2022 Aug 15, 2022	BUY	$1.61 - $4.68 $46,825 - $136,113	29,084 New	29,084 $47,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.